PET/CT Method Can Help Detect ‘Hardening’ of the Arteries
Atherosclerosis (hardening of the arteries) is a potentially serious condition where arteries become clogged by a build-up of fatty deposits known as ‘plaques’. One of the key constituents in these deposits is calcium. In some people, pieces from the calcified artery can break away. When this happens, the artery supplies the heart or brain with blood, which can lead to heart attack or stroke.
For this study, researchers injected patients with sodium fluoride that had been tagged with a tiny amount of a radioactive tracer. Using a combination of PET and CT scanning techniques, the researchers were able to track the progress of the tracer as it moved around the body.
“Sodium fluoride is commonly found in toothpaste as it binds to calcium compounds in our teeth’s enamel,” explains Dr. Anthony Davenport from the Department of Experimental Medicine and Immunotherapeutics at the University of Cambridge, who led the study. “In a similar way, it also binds to unstable areas of calcification in arteries and so we’re able to see, by measuring the levels of radioactivity, exactly where the deposits are building up. In fact, this new emerging technique is the only imaging platform that can non-invasively detect the early stages of calcification in unstable atherosclerosis.”
Following their sodium fluoride scans, the patients had surgery to remove calcified plaques and the extracted tissue was imaged, this time at higher resolution, using a laboratory PET/CT scanner and an electron microscope. This confirmed that the radiotracer accumulates in areas of active, unstable calcification whilst avoiding surrounding tissue, according to researchers.
The new imaging technique "will allow us to use current treatments more effectively, by giving them to those patients at highest risk," notes Dr. James Rudd, a cardiologist and researcher from the Department of Cardiovascular Medicine at the University of Cambridge. After further work, Dr. Rudd says it may be possible to use this technique to test how well new medicines perform at preventing the development of atherosclerosis.
Source and image credit: University of Cambridge
Published on : Tue, 14 Jul 2015
THE VEVO MD IS THE WORLD’S FIRST ULTRA HIGH FREQUENCY ULTRASOUND SYSTEM DESIGNED FOR CLINICAL USE WITH FREQUENCIES UP TO 70 MHz. This groundbreaking technology opens up new possibilities for medical imaging that have never been seen before. Whether...
UltraDrape is an innovative dressing designed for use during Ultrasound-Guided Peripheral Intravenous (UGPIV) that provides dual-action barrier and securement in one.
With its customer driven design, amazing usability and freedom of movement, Agfa's DR 100s offers your facility a new force in mobile imaging. Combining a remarkably narrow width and light weight with a powerful generator and imaging processing, it puts...
Better detection. Clinically superior. Low dose.** What if we could find breast cancers earlier? See lesions more clearly? Reduce the number of unnecessary biopsies? Questions like these inspired Hologic researchers and scientists to develop Hologic...
Introducing a new chapter in ultrasound visualization technology. X-Porte was developed from the ground up to incorporate a breakthrough, proprietary beam-forming technology: XDI (Extreme Definition Imaging). This signal analysis algorithm shapes...